Neurocrine Bioscience buy UBS Group AG
Start price
28.05.24
/
50%
€129.45
Target price
28.05.25
€177.37
Performance (%)
4.09%
Price
14:14
€134.75
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 4.09%. This prediction currently runs until 28.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.738% | 1.738% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at UBS Group AG from $174.00 to $193.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat